(5-fluoro-3-pyridinyl)-[4-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperazin-1-yl]methanone
C20H26FN7O — CID 122333891
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5-fluoro-3-pyridinyl)-[4-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperazin-1-yl]methanone
(5-fluoro-3-pyridinyl)-[4-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperazin-1-yl]methanone (PubChem CID 122333891) has the molecular formula C20H26FN7O and a molecular weight of 399.47 g/mol. Its IUPAC name is (5-fluoro-3-pyridinyl)-[4-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperazin-1-yl]methanone.
Molecular Properties
| Compound Name | (5-fluoro-3-pyridinyl)-[4-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperazin-1-yl]methanone |
|---|---|
| PubChem CID | 122333891 |
| Molecular Formula | C20H26FN7O |
| Molecular Weight | 399.47 g/mol |
| Exact Mass | 399.22 |
| IUPAC Name | (5-fluoro-3-pyridinyl)-[4-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]piperazin-1-yl]methanone |
| SMILES | Cc1cc(N2CCN(C)CC2)nc(N2CCN(C(=O)c3cncc(F)c3)CC2)n1 |
| InChI | InChI=1S/C20H26FN7O/c1-15-11-18(26-5-3-25(2)4-6-26)24-20(23-15)28-9-7-27(8-10-28)19(29)16-12-17(21)14-22-13-16/h11-14H,3-10H2,1-2H3 |
| InChIKey | BNNSIWATBHACEB-UHFFFAOYSA-N |
| XLogP | 1.03 |
| TPSA | 68.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 399.47 |
| LogP ≤ 5 | 1.03 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122333891 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.